Part,  Chapter, Paragraph

 1   II,     5.  1.  1|        cirrhosis and other chronic liver diseases; nephrological
 2   II,     5.  1.  1|            after 10 months of age.~Liver Cirrhosis~The patterns in
 3   II,     5.  5.  3|            use of nicotine) or the liver (due to alcohol consumption).
 4   II,     5. 12    |                              5.12. Liver cirrhosis~ ~
 5   II,     5. 12.  1|          of HBV and HCV in causing liver cirrhosis, this Chapter
 6   II,     5. 12.  3|        bleeding, better control of liver functions and liver transplantation –
 7   II,     5. 12.  3|     control of liver functions and liver transplantationmay also
 8   II,     5. 12.  3|     cirrhosis of deaths from acute liver intoxication or failure (
 9   II,     5. 12.  3|            subjects with cirrhotic liver; further attention to diagnosis
10   II,     5. 12.  3|        certification validity from liver disease is therefore required.~ ~ ~
11   II,     5. 12.  5|        cirrhosis and other chronic liver diseases is based on the
12   II,     5. 12.  6|    provided by the introduction of liver transplantation.~ ~The impact
13   II,     5. 12.  6|          long-term prognosis after liver transplantation and the
14   II,     5. 12.  6|     proportion of cirrhosis cases, liver transplantation is performed
15   II,     5. 12.  6|    identification and diagnosis of liver cancer foci. Thus, at least
16   II,     5. 12.  6|         transplantation on chronic liver disease would be attributed
17   II,     5. 12.  6|     disease would be attributed to liver cancer following cirrhosis,
18   II,     5. 12.  6|      itself.~ ~A wider adoption of liver transplantation in the future
19   II,     5. 12.  7|           future burden of chronic liver disease in the United States.
20   II,     5. 12.  7|        Decarli A (1997): Trends of liver cirrhosis mortality in Europe,
21   II,     5. 12.  7|            the risk of symptomatic liver cirrhosis. Hepatology 27:
22   II,     5. 12.  7|           trends in mortality from liver cirrhosis, 1955 to 1990.
23   II,     5. 12.  7|          DA, McCambridge J (2006): Liver cirrhosis mortality rates
24   II,     5. 12.  7|          Evaluation of efficacy of liver transplantation in alcoholic
25   II,     5. 12.  7|            alcohol consumption and liver cirrhosis mortality in 14
26   II,     5. 12.  7|      Schuppan D, Afdhal NH (2008): Liver Cirrhosis. Lancet 371: 838–
27   II,     5. 12.  7|        three decades in Italy. Dig Liver Dis 37:622-627.~ ~World
28   II,     6.  3.  3|           B is an infection of the liver caused by hepatitis B virus (
29   II,     6.  3.  3|   chronically infected can develop liver cirrhosis (25%) or cancer (
30   II,     6.  3.  3|          of those go on to develop liver cirrhosis or cancer. Injecting
31   II,     6.  3.  6|          is a viral disease of the liver caused by hepatitis A virus (
32   II,     9.  3.  1|           prostate, testis, bowel, liver, kidney, oesophagus and
33   II,     9.  3.  1|         was responsible for 30% of liver transplants in Europe (European
34  III,    10.  2.  1|         cavities~- Nasal sinuses~- Liver~- Chronic obstructive pulmonary
35  III,    10.  2.  1|      alcohol increases the risk of liver cirrhosis and acute and
36  III,    10.  2.  1|      reduction (almost 3 times) of liver cirrhosis (Figure 10.2.1.
37  III,    10.  2.  1|             larynx (upper airway), liver and female breast, and -
38  III,    10.  2.  1|       causes:~- 45,000 deaths from liver cirrhosis~- 50,000 cancer
39  III,    10.  2.  1|             accidents), stroke and liver disease (across the EU15),
40  III,    10.  2.  1|           this to be mainly due to liver cirrhosis and alcohol-related
41  III,    10.  2.  1|          reductions in deaths from liver cirrhosis, mortality rates
42  III,    10.  2.  1| ultraviolet light and completed in liver and kidney. Therefore, under
43  III,    10.  4.  2|          products~ ~Effects on the liver,~thyroid, immune system~
44  III,    10.  4.  2|            chunks in~animal feed~ ~Liver cancer (in~combination with~
45  III,    10.  4.  2|        combination with~hepatitis) Liver~abnormalities, tumours~genotoxic
46  III,    10.  4.  2|           Possible oesophageal~and liver cancer~ ~In preparation~
47  III,    10.  4.  2|         herbal teas~Effects in the liver,~carcinogenic~ ~NL; EU in
48   IV,    11.  5.  1|      failure of organs such as the liver, lung and heart, it is the
49   IV,    11.  5.  1|          expanding to the field of liver, heart, lung and tissue
50   IV,    11.  5.  2|    ERA-EDTA Registry: htt European Liver Transplant Registry: htt
51   IV,    11.  5.  2|       Registry (REDMO): ht Spanish Liver Transplant Registry: htt
52   IV,    11.  5.  4|         while waiting for a heart, liver or lung transplant usually
53   IV,    11.  5.  4|      transplant activity and 5% of liver transplantation. Although
54   IV,    11.  5.  6|           document~1997Recom 16 on liver transplantation from living
55   IV,    12.  2    |          reductions in deaths from liver cirrhosis, fatality rates
56   IV,    13.  7    |     treatment for end-stage renal, liver, lung and heart failure.~ ~
57  Key,   Ap5.  0.  0|   Lithuania~live-birth~live-births~liver~longevity~Luxembourg~lymphogranuloma~